An interesting study by Wang X et al. [104] has shown that the small-molecule ADAR1 inhibitor ZYS-1 can dramatically suppress prostate cancer cell growth and inhibit metastasis, and that it has a favorable safety profile. Here, ADAR is linked to prostate cancer.